These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1280300)

  • 1. Gonadotropin-releasing hormone antagonists with N omega-triazolylornithine, -lysine, or -p-aminophenylalanine residues at positions 5 and 6.
    Rivier J; Porter J; Hoeger C; Theobald P; Craig AG; Dykert J; Corrigan A; Perrin M; Hook WA; Siraganian RP
    J Med Chem; 1992 Nov; 35(23):4270-8. PubMed ID: 1280300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone antagonists: novel members of the azaline B family.
    Rivier JE; Jiang G; Porter J; Hoeger CA; Craig AG; Corrigan A; Vale W; Rivier CL
    J Med Chem; 1995 Jul; 38(14):2649-62. PubMed ID: 7629804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N omega-cyanoguanidino moieties.
    Theobald P; Porter J; Rivier C; Corrigan A; Hook W; Siraganian R; Perrin M; Vale W; Rivier J
    J Med Chem; 1991 Aug; 34(8):2395-402. PubMed ID: 1714956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
    Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J
    Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6.
    Jiang G; Stalewski J; Galyean R; Dykert J; Schteingart C; Broqua P; Aebi A; Aubert ML; Semple G; Robson P; Akinsanya K; Haigh R; Riviere P; Trojnar J; Junien JL; Rivier JE
    J Med Chem; 2001 Feb; 44(3):453-67. PubMed ID: 11462984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin releasing hormone antagonists: novel structures incorporating N omega-cyano modified guanidine moieties.
    Rivier J; Theobald P; Porter J; Perrin M; Gunnet J; Hahn DW; Rivier C
    Biochem Biophys Res Commun; 1991 Apr; 176(1):406-12. PubMed ID: 1850267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betidamino acid scan of the GnRH antagonist acyline.
    Jiang G; Miller C; Koerber SC; Porter J; Craig AG; Bhattacharjee S; Kraft P; Burris TP; Campen CA; Rivier CL; Rivier JE
    J Med Chem; 1997 Nov; 40(23):3739-48. PubMed ID: 9371239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the antigonadotropic activity of three GnRH antagonists (Nal-Glu, Antide and Cetrorelix) in a non-human primate model (Macaca fascicularis).
    Weinbauer GF; Nieschlag E
    Andrologia; 1993; 25(3):141-7. PubMed ID: 8517553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iterative approach to the discovery of novel degarelix analogues: substitutions at positions 3, 7, and 8. Part II.
    Samant MP; Gulyas J; Hong DJ; Croston G; Rivier C; Rivier J
    J Med Chem; 2005 Jul; 48(15):4851-60. PubMed ID: 16033265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro.
    Rivier JE; Porter J; Rivier CL; Perrin M; Corrigan A; Hook WA; Siraganian RP; Vale WW
    J Med Chem; 1986 Oct; 29(10):1846-51. PubMed ID: 2428978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.
    Dubourdieu S; Charbonnel B; D'Acremont MF; Carreau S; Spitz IM; Bouchard P
    J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiovulatory antagonists of LHRH related to antide.
    Flouret G; Arnold ZS; Majewski T; Petousis NH; Mahan K; Farooqui F; Blum KA; Konopinska D; Natarajan S; Crich D
    J Pept Sci; 1995; 1(2):89-108. PubMed ID: 9222987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of potent cyclic gonadotropin releasing hormone antagonists.
    Rivier J; Kupryszewski G; Varga J; Porter J; Rivier C; Perrin M; Hagler A; Struthers S; Corrigan A; Vale W
    J Med Chem; 1988 Mar; 31(3):677-82. PubMed ID: 3279211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose administration of the gonadotropin-releasing hormone antagonist, Nal-Lys (antide) to healthy men.
    Bagatell CJ; Conn PM; Bremner WJ
    Fertil Steril; 1993 Oct; 60(4):680-5. PubMed ID: 8405525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 90-day subcutaneous toxicity and fertility study of a LHRH antagonist in rats.
    Sundaram K; Didolkar AK; Keizer-Zucker A; DeJesus W; Rivier J; Vale W; Bardin CW
    Fundam Appl Toxicol; 1990 May; 14(4):734-44. PubMed ID: 1694507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent gonadotropin releasing hormone antagonists with low histamine-releasing activity.
    Nestor JJ; Tahilramani R; Ho TL; Goodpasture JC; Vickery BH; Ferrandon P
    J Med Chem; 1992 Oct; 35(21):3942-8. PubMed ID: 1279174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.
    Hall JE; Whitcomb RW; Rivier JE; Vale WW; Crowley WF
    J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and theoretical conformational studies of gonadotropin-releasing hormone analogs containing tetrahydroisoquinoline carboxylic acid.
    Koerber SC; Ibea M; Hagler AT; Rivier CL; Rivier JE
    Biochem Biophys Res Commun; 1992 Sep; 187(2):1035-41. PubMed ID: 1530601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antide and related antagonists of luteinizing hormone release with long action and oral activity.
    Ljungqvist A; Feng DM; Hook W; Shen ZX; Bowers C; Folkers K
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8236-40. PubMed ID: 2460863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased histamine release by luteinizing hormone-releasing hormone antagonists obtained upon translocation of the cationic amino acid from position 8 to position 7.
    Flouret G; Mahan K; Majewski T
    J Med Chem; 1992 Feb; 35(4):636-40. PubMed ID: 1371810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.